Liger Medical

Cervical cancer is the 4th most common cancer in women worldwide, taking more than 300,000 lives each year due to gaps in screening, diagnosis, and treatment.

Where Women are Lost

Most cervical cancer programs depend on multiple visits.

As much as 60% of women screened in an initial visit do not return for treatment.

These gaps, not a lack of available tools, are a primary driver of preventable disease and death.

3 Easy Steps

Screen

Learn More

Triage

Identify Lesions using Digital Colposcopy and Risk Stratification

HPV genotype and image classification risk stratification chart

Learn More

Treat

Provide Same-Visit treatment with thermal ablation

Thermal ablation device, application diagram, and carrying case

Learn More

One visit is all it takes

Early risk identification, precise triage, and timely treatment work together within a single, connected approach.

Liger Medical's connected technologies help providers deliver cervical pre-cancer care in a single visit—from HPV screening and colposcopic evaluation to same-day treatment. By keeping patients in care when it matters most, we support efforts to reduce loss to follow-up and expand access to timely care.

References:

World Health Organization. Cervical cancer. Available at: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer
World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. 2nd ed. Geneva: World Health Organization; 2024.
World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions: use of HPV DNA genotyping. Geneva: World Health Organization; 2026. Available at: https://iris.who.int/items/7eac93e4-6d76-4d5f-a32d-9fd4c43fd3a7
Centers for Disease Control and Prevention. HPV Vaccination. Available at: https://www.cdc.gov/hpv/vaccines/index.html
Randall TC, Sauvaget C, Muwonge R, Trimble EL, Jeronimo J. Feasibility, acceptability, safety and efficacy of thermal ablation for cervical precancer. Preventive Medicine. 2019;118:81–91.
de Sanjosé S, et al. Advances in HPV‑based screening and treatment strategies for cervical cancer prevention. eLife. 2023;12:RP91469.
Journal of the National Cancer Institute. Effectiveness of thermal ablation compared with cryotherapy for cervical precancer treatment. Advance Access, March 18, 2025.

The Liger Medical Single Visit Program

Overcoming loss to follow-up within a single visit

High proportions of loss to follow-up for cervical cancer patients have been reported in low and mid range income countries, ranging between 41–69%.2,3. The Liger Medical screening and treatment solutions reduces loss to follow up and increasing efficacy in diagnosis and treatment programs